Release of complement regulatory proteins from ocular surface cells in infections

被引:18
作者
Cocuzzi, E
Guidubaldi, J
Bardenstein, DS
Chen, R
Jacobs, MR
Medof, ME
机构
[1] Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr Vis Res, Cleveland, OH 44106 USA
关键词
complement; DAF; CD59; phospholipases;
D O I
10.1076/ceyr.21.5.856.5539
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. The decay accelerating factor (DAF or CD55) and the membrane inhibitor of reactive lysis (MIRL or CD59), two complement regulatory proteins that protect self cells from autologous complement-mediated injury, are attached to corneal and conjunctival epithelial cells by glycosylphosphatidylinositol (GPI) anchors. We sought to 1) determine the frequency with which bacteria recovered from patients with infections of the eye elaborate factors that can remove these surface proteins from ocular cells, 2) determine the spectrum of bacteria from other sites that have similar effects, and 3) establish the time interval required for reconstitution of the two regulators. Methods. Culture supernatants of 18 ocular isolates [P. aeruginosa (n = 3), S. marcescens (n = 1), S. epidermidis (n = 9), and S. aureus (n = 5)], and > 100 other clinical specimens isolated in the hospital's microbiology laboratory [P. mirabilis (n = 1), S. aureus (n = 65), S. epidermidis (n = 24), B. cereus (n = 12), H. influenzae (n = 15), and Enterobacter sp. (n = 21)] were incubated at 37 degrees C for various times with conjunctival epithelial cells, conjunctival fibroblasts or HeLa cells and the release of DAF and CD59 proteins from the surfaces of the cells analyzed by 2-site immunoradiometric assays and by Western blotting. The kinetics of recovery of DAF and CD59 expression on the cells was measured by flow cytometry. Results. DAF and/or CD59 release from the cell monolayers varied from < 5% to > 99% at as much as a 1:81 dilution of the supernatant from some bacteria. On conjunctival epithelial cells, more than 8 hr was required for 44% recovery of DAF expression and for 50% recovery of CD59 expression. Conclusions. Bacteria produce phospholipases and/or other enzymes which can efficiently remove DAF and CD59 from ocular cell surfaces. This phenomenon may correlate with their in vivo pathogenicity.
引用
收藏
页码:856 / 866
页数:11
相关论文
共 47 条
[1]   ULCERATIVE KERATITIS ASSOCIATED WITH CONTACT-LENS WEAR [J].
ALFONSO, E ;
MANDELBAUM, S ;
FOX, MJ ;
FORSTER, RK .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (04) :429-433
[2]   EFFECTS OF DIETHYLDITHIOCARBAMATE ON THE TOXICOKINETICS OF CADMIUM CHLORIDE IN MICE [J].
ANDERSEN, O ;
NIELSEN, JB .
TOXICOLOGY, 1989, 55 (1-2) :1-14
[3]   CHARACTERIZATION OF PSEUDOMONAS-AERUGINOSA-INDUCED MDCK CELL INJURY - GLYCOSYLATION-DEFECTIVE HOST-CELLS ARE RESISTANT TO BACTERIAL KILLING [J].
APODACA, G ;
BOMSEL, M ;
LINDSTEDT, R ;
ENGEL, J ;
FRANK, D ;
MOSTOV, KE ;
WIENERKRONISH, J .
INFECTION AND IMMUNITY, 1995, 63 (04) :1541-1551
[4]   Detection of complement regulatory proteins on soft contact lenses [J].
Bardenstein, DS ;
Sauer, S ;
Szczotka, L ;
Medof, ME .
CURRENT EYE RESEARCH, 1997, 16 (12) :1270-1273
[5]  
Bardenstein DS, 1999, INVEST OPHTH VIS SCI, V40, P519
[6]   LOCALIZATION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX INHIBITOR (CD59) IN HUMAN CONJUNCTIVA AND LACRIMAL GLAND [J].
BARDENSTEIN, DS ;
DIETZ, Y ;
LASS, JH ;
MEDOF, ME .
CURRENT EYE RESEARCH, 1994, 13 (12) :851-855
[7]   Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: Prototypes of pore-forming bacterial cytolysins [J].
Bhakdi, S ;
Bayley, H ;
Valeva, A ;
Walev, I ;
Walker, B ;
Weller, U ;
Kehoe, M ;
Palmer, M .
ARCHIVES OF MICROBIOLOGY, 1996, 165 (02) :73-79
[8]   ALPHA-TOXIN OF STAPHYLOCOCCUS-AUREUS [J].
BHAKDI, S ;
TRANUMJENSEN, J .
MICROBIOLOGICAL REVIEWS, 1991, 55 (04) :733-751
[9]   LACRIMAL IMMUNOGLOBULINS AND COMPLEMENT QUANTIFIED BY COUNTER-IMMUNOELECTROPHORESIS [J].
BLUESTONE, R ;
EASTY, DL ;
GOLDBERG, LS ;
JONES, BR ;
PETTIT, TH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1975, 59 (05) :279-281
[10]  
BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579